ストックスクリーナーアプリを入手
63.34
4.56%
2.7697
Moderna Inc (MRNA) 最新ニュース
Bank of America Corp DE Sells 388,494 Shares of Moderna, Inc. $MRNA - MarketBeat
Could Arbutus Biopharma Corporation (ABUS) Turn its Moderna, Inc. (MRNA) Settlement Into a Lasting Biotech Advantage? - finance.yahoo.com
FDA approval of mFLUSIVA highlights Moderna’s position in mRNA market - finance.yahoo.com
Moderna, Inc. (MRNA) Stock Analysis: Navigating Potential Amidst A -14.07% Downside - DirectorsTalk Interviews
Moderna, Inc. $MRNA Shares Acquired by Contravisory Investment Management Inc. - MarketBeat
Watch RocketLab Rises on Space Interest; Moderna Moves on Flu Shot | Stock Movers - Bloomberg.com
Moderna | History, Innovation, Challenges, & Facts - Encyclopedia Britannica
Moderna, Inc. $MRNA Shares Acquired by Empowered Funds LLC - MarketBeat
Moderna jumps as FDA flu-shot approval reinforces recent business momentum - Quiver Quantitative
FAQ: What mFLUSIVA's Approval May Signal for the Future of mRNA Vaccine Development - BioPharm International
Rule 10b5-1 plan drives Moderna, Inc. (NASDAQ: MRNA) CEO stock sales - Stock Titan
Moderna mRNA flu shot wins FDA approval but awaits CDC recommendations - Pharmaceutical Technology
Moderna (MRNA) Wins FDA Flu Vaccine Approval On Questions Over Whether The Stock Is Fully Valued - simplywall.st
Moderna Q2 Earnings Call Highlights Cost Cuts and Pipeline Milestones - finance.yahoo.com
Moderna Inc. Stock Climbs 9.9%, Outperforms Peers - Bitget
For Moderna’s Greenlit mRNA Flu Vaccine, Payoff Is a Ways Off - finance.yahoo.com
What Moderna is and how it built its mRNA vaccine platform - qz.com
FDA Approves New, More Effective Flu Vaccine From Moderna - People.com
Expert available: FDA approves 1st mRNA flu shot, from Moderna | Newswise - Newswise
Moderna Gets FDA Approval for mRNA Flu Vaccine, But CDC Input Still Uncertain - MedCity News
Opinion | The FDA, Replimune and a New Flu Shot - WSJ
FDA approves Moderna’s mFlu vaccine for adults 50 and older - CBS News
Here’s what the first mRNA flu vaccine could mean for flu season - Science News
The flu shot finally gets an upgrade - vox.com
Moderna Stock Flashing Intriguing ‘Buy The Dip’ Signal - Forbes
Moderna shares slide despite mFlusiva success 📉 What's next for the mRNA vaccines market giant? - XTB.com
MRNA Stock Gets a Shot in the Arm as FDA Approves Moderna Flu Vaccine - finance.yahoo.com
FDA approved Moderna's mRNA flu vaccine after initially refusing to review it - qz.com
Moderna wins FDA approval for first mRNA-based flu shot - americanbazaaronline.com
Moderna Just Got FDA Clearance for Flu Vaccine. The Stock Is Sliding. - Barron's
FDA approves Moderna mRNA flu shot - CNBC
FDA Approves mFLUSIVA, First mRNA-Based Flu Vaccine - Drug Topics
Beyond COVID: Moderna Wins FDA Approval for Its Seasonal Flu Vaccine - benzinga.com
Moderna’s First mRNA Flu Shot Just Won FDA Approval. Now Researchers See Potential for HIV and Malaria - inc.com
Moderna's flu shot wins FDA approval after initial regulatory battle - The Business Journals
The mRNA technology behind Moderna’s Covid vaccine reaches the flu - The Guardian
FDA Approves First mRNA Flu Vaccine in Win for Moderna After Arduous Review - WSJ
Moderna’s mRNA Flu Shot Wins US Approval in FDA Turnaround - Bloomberg.com
FDA approves Moderna’s mRNA flu vaccine - Healthcare Dive
Moderna Stock Climbs on Flu Vaccine Approval - Schaeffer's Investment Research
U.S. approves Moderna’s mRNA vaccine for flu—the first of its kind - Scientific American
U.S. FDA approves first mRNA flu shot from Moderna - cnbc.com
Moderna’s flu shot crosses FDA finish line, bouncing back from regulatory roadblock - BioSpace
FDA approves first mRNA flu vaccine - The Hill
Edgestream Partners L.P. Sells 28,698 Shares of Moderna, Inc. $MRNA - MarketBeat
Moderna, Inc. (NASDAQ:MRNA) Given Average Recommendation of "Reduce" by Analysts - MarketBeat
FDA approves Moderna's mRNA seasonal flu vaccineABC News - ABC News - Breaking News, Latest News and Videos
Moderna receives FDA approval for first mRNA flu vaccine - Investing.com
Moderna's mFlusiva Approved as First mRNA-Based Influenza VaccineMPR - Medical Professionals Reference
Moderna gains approval of first-ever mRNA flu vaccine - Seeking Alpha
FDA approves Moderna's mRNA flu vaccine after initial pushback - CBS News
F.D.A. Approves Moderna’s mRNA Flu Vaccine - The New York Times
Moderna's first mRNA flu vaccine approved for adults 50+ - Stock Titan
Moderna Receives U.S. FDA Approval for Influenza Vaccine mFLUSIVA - finance.yahoo.com
Moderna Appeals District Court Infringement Judgment over COVID Vaccines - JD Supra
Moderna, Inc. SEC Filing (Aug 5, 2026) - Stock Titan
Why Is Moderna Stock Gaining Wednesday?Moderna (NASDAQ:MRNA) - benzinga.com
Moderna, Inc. $MRNA Shares Bought by Quantinno Capital Management LP - MarketBeat
Are Wall Street Analysts Predicting Moderna Stock Will Climb or Sink? - finance.yahoo.com
Cetera Investment Advisers Has $4.13 Million Stake in Moderna, Inc. $MRNA - MarketBeat
Moderna begins Phase 1 clinical trial of Ebola vaccine against strain behind DRC outbreakABC News - ABC News - Breaking News, Latest News and Videos
Moderna begins human trial of experimental Ebola vaccine in Canada - The Seattle Times
Moderna begins first human trial of Bundibugyo Ebola vaccine - Reuters
Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna's Investigational Vaccine Against Bundibugyo Ebolavirus - finance.yahoo.com
Sei Investments Co. Acquires 55,939 Shares of Moderna, Inc. $MRNA - MarketBeat
Moderna, Inc. Revenue Breakdown – NASDAQ:MRNA - TradingView
Amicus Brief in Arbutus v. Moderna - Hudson Institute
Hamilton Wealth LLC Sells 24,338 Shares of Moderna, Inc. $MRNA - MarketBeat
Moderna, Inc. (MRNA) Stock Analysis: Exploring a 9.75% Potential Downside in the Biotech Leader - DirectorsTalk Interviews
Militia Capital Management LLC Buys New Shares in Moderna, Inc. $MRNA - MarketBeat
Amundi Reduces Holdings in Moderna, Inc. $MRNA - MarketBeat
Moderna, Inc. $MRNA Position Reduced by The Manufacturers Life Insurance Company - MarketBeat
California State Teachers Retirement System Purchases 58,529 Shares of Moderna, Inc. $MRNA - MarketBeat
Moderna Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Moderna, Inc. Q2 2026 Earnings Call Summary - finance.yahoo.com
Moderna, Inc. 2026: Revenue $145M, Net income ($782M), EPS ($1.97) — 10-Q Summary - TradingView
Is Moderna Inc (MRNA) Overvalued After Q2 Earnings Report? EPS o - GuruFocus
1.94%
0.08%
大文字化:
|
ボリューム (24 時間):